Janux Therapeutics Ownership | Who Owns Janux Therapeutics?
Janux Therapeutics Ownership Summary
Janux Therapeutics is owned by 5.58% institutional investors, 6.59% insiders, and 87.83% retail investors. Ra capital management is the largest institutional shareholder, holding 18.11% of JANX shares. Fidelity Growth Compy Commingled Pl S is the top mutual fund, with 3.72% of its assets in Janux Therapeutics shares.
JANX Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Janux Therapeutics | 5.58% | 6.59% | 87.83% |
Sector | Healthcare Stocks | 279.18% | 10.62% | -189.80% |
Industry | Biotech Stocks | 63.96% | 10.74% | 25.30% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Ra capital management | 11.19M | 18.11% | $302.12M |
Fmr | 8.67M | 15.87% | $464.19M |
Janus henderson group | 3.56M | 6.52% | $190.62M |
Adage capital partners gp | 3.06M | 5.60% | $163.93M |
Paradigm biocapital advisors lp | 3.33M | 5.39% | $89.91M |
Blackrock funding, inc. /de | 2.73M | 4.99% | $145.94M |
Blackrock | 2.34M | 4.78% | $98.19M |
Vanguard group | 2.14M | 3.91% | $114.38M |
Woodline partners lp | 1.85M | 3.39% | $99.17M |
Cormorant asset management, lp | 2.00M | 3.24% | $54.00M |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Logos global management lp | 1.25M | 7.83% | $66.92M |
Prosight management, lp | 689.90K | 6.12% | $18.63M |
Ra capital management | 11.19M | 5.05% | $302.12M |
Ally bridge group (ny) | 90.29K | 4.14% | $4.83M |
Paradigm biocapital advisors lp | 3.33M | 4.12% | $89.91M |
Cormorant asset management, lp | 2.00M | 4.06% | $54.00M |
Avidity partners management lp | 741.90K | 3.90% | $39.72M |
Ecor1 capital | 1.47M | 2.98% | $78.69M |
Stempoint capital lp | 342.06K | 2.94% | $9.24M |
Bioimpact capital | 567.19K | 2.63% | $15.31M |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Janus henderson group | 3.56M | 0.10% | 1.04M |
Holocene advisors, lp | 1.02M | 0.17% | 1.02M |
State street | 1.40M | 0.00% | 1.00M |
Adage capital partners gp | 3.06M | 0.29% | 986.75K |
Price t rowe associates inc /md/ | 1.11M | 0.01% | 950.56K |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Rtw investments, lp | - | - | -1.00M |
Driehaus capital management | - | - | -515.65K |
Vestal point capital, lp | - | - | -485.00K |
Bvf inc/il | - | - | -441.53K |
Samlyn capital | - | - | -324.70K |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Holocene advisors, lp | 1.02M | 0.17% | 1.02M | $54.35M |
Pictet asset management sa | 384.80K | 0.02% | 384.80K | $20.60M |
Rock springs capital management lp | 204.47K | 0.42% | 204.47K | $10.95M |
Tudor investment corp et al | 174.35K | 0.02% | 174.35K | $4.71M |
First trust advisors lp | 128.06K | 0.01% | 128.06K | $6.86M |
Sold Out
Holder | Change |
---|---|
Quantbot technologies lp | -1.00 |
National bank of canada /fi/ | -1.00 |
Corecap advisors | -9.00 |
Capital performance advisors llp | -17.00 |
Abich financial wealth management | -20.00 |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Mar 31, 2025 | 7 | -96.93% | 3,447,727 | -94.63% | 5 | 0.04% | 5 | -96.82% | 1 | -97.73% |
Dec 31, 2024 | 213 | 29.09% | 61,331,550 | 34.45% | 112 | 1.61% | 149 | 67.42% | 37 | -22.92% |
Sep 30, 2024 | 164 | 2.50% | 45,609,396 | 2.07% | 83 | 1.24% | 88 | -20.00% | 48 | 45.45% |
Jun 30, 2024 | 159 | 28.23% | 44,686,120 | 5.66% | 91 | 0.99% | 109 | 26.74% | 33 | 17.86% |
Mar 31, 2024 | 124 | 87.88% | 42,293,771 | 26.24% | 96 | 1.79% | 86 | 109.76% | 28 | 154.55% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Fidelity Growth Compy Commingled Pl S | 2.20M | 3.72% | - |
Fidelity Growth Compy Commingled Pl O | 1.65M | 3.16% | 20.65K |
Fidelity Growth Company Fund | 1.57M | 2.65% | - |
Vanguard Total Stock Mkt Idx Inv | 1.34M | 2.27% | - |
Vanguard US Total Market Shares ETF | 1.00M | 1.69% | 193.50K |
iShares Russell 2000 ETF | 806.95K | 1.36% | 396.00 |
Fidelity Select Health Care | 699.39K | 1.18% | 9.70K |
Fidelity Small Cap Growth | 695.07K | 1.17% | 10.78K |
SPDR® S&P Biotech ETF | 634.92K | 1.07% | 822.00 |
Janus Henderson Global Life Sciences D | 527.16K | 0.89% | -13.32K |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
May 01, 2025 | Meyer Andrew Hollman | Chief Business Officer | Sell | $13.04K |
May 01, 2025 | Meyer Andrew Hollman | Chief Business Officer | Sell | $93.70K |
Apr 21, 2025 | Meyer Andrew Hollman | Chief Business Officer | Sell | $100.02K |
Mar 06, 2025 | RA CAPITAL MANAGEMENT, L.P. | Buy | $11.45M | |
Mar 05, 2025 | RA CAPITAL MANAGEMENT, L.P. | Buy | $1.17M |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2025 Q2 | - | 3 |
2025 Q1 | 4 | 11 |
2024 Q4 | 1 | 23 |
2024 Q3 | - | 33 |
2024 Q2 | - | 8 |
JANX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools